Literature DB >> 34517012

Depression in Female Adolescents with Heavy Menstrual Bleeding.

Angela C Weyand1, Kate D Fitzgerald2, Mary McGrath3, Vibhuti Gupta4, Thomas M Braun5, Elisabeth H Quint6, Sung W Choi3.   

Abstract

OBJECTIVE: To assess the degree to which heavy menstrual bleeding is associated with depression, independent of hormonal contraception. STUDY
DESIGN: We performed a retrospective cohort study of 1168 female adolescents 9-18 years old presenting to general pediatricians for heavy menstrual bleeding or well visits. Depression was the primary outcome and defined as a diagnosis in the health record. Univariable and multivariable regression models were fit to the data to identify factors associated with depression diagnosis.
RESULTS: In total, 581 adolescents with heavy menstrual bleeding and 587 without heavy menstrual bleeding were included. Depression diagnoses occurred with greater frequency in youth with heavy menstrual bleeding compared with those without heavy menstrual bleeding (50.9% vs 24.2% P < .001; risk ratio 1.67, 95% CI 1.39-2.01) but did not significantly differ between those taking vs not taking hormonal contraception (risk ratio 0.99; 95% CI 0.84-1.17). Most patients with depression and heavy menstrual bleeding developed depression following or concurrent with heavy menstrual bleeding (261/296, 88%). Of these, 199 of 261 (76%) were treated with hormonal contraception, but the majority (168/199; 84%) were diagnosed with depression before initiation.
CONCLUSIONS: Heavy menstrual bleeding is associated with depression diagnosis in female adolescents. The use of hormonal contraception was not associated with depression diagnosis in multivariable analysis, covarying heavy menstrual bleeding, age, body mass index, anxiety, sexual activity, and substance use. As hormonal contraception is often used to treat heavy menstrual bleeding, heavy menstrual bleeding may be partially driving previous reports of increased depression risk in those taking hormonal contraception.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34517012      PMCID: PMC9055780          DOI: 10.1016/j.jpeds.2021.09.007

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   6.314


  22 in total

1.  Combined oral contraceptive use is associated with both improvement and worsening of mood in the different phases of the treatment cycle-A double-blind, placebo-controlled randomized trial.

Authors:  Cecilia Lundin; Kristina Gemzell Danielsson; Marie Bixo; Lena Moby; Hanna Bengtsdotter; Izabella Jawad; Lena Marions; Jan Brynhildsen; Agota Malmborg; Ingela Lindh; Inger Sundström Poromaa
Journal:  Psychoneuroendocrinology       Date:  2016-11-29       Impact factor: 4.905

2.  Current and past depressive symptoms and contraceptive effectiveness level method selected among women seeking reproductive health services.

Authors:  Julia R Steinberg; Nancy E Adler; Kirsten M Thompson; Carolyn Westhoff; Cynthia C Harper
Journal:  Soc Sci Med       Date:  2018-08-13       Impact factor: 4.634

3.  Anxiety, depression, and menstrual symptoms among freshman medical students.

Authors:  S Sherry; M T Notman; C C Nadelson; F Kanter; P Salt
Journal:  J Clin Psychiatry       Date:  1988-12       Impact factor: 4.384

4.  Association of Use of Oral Contraceptives With Depressive Symptoms Among Adolescents and Young Women.

Authors:  Anouk E de Wit; Sanne H Booij; Erik J Giltay; Hadine Joffe; Robert A Schoevers; Albertine J Oldehinkel
Journal:  JAMA Psychiatry       Date:  2020-01-01       Impact factor: 21.596

5.  Association of past and recent major depression and menstrual characteristics in midlife: Study of Women's Health Across the Nation.

Authors:  Joyce T Bromberger; Laura L Schott; Karen A Matthews; Howard M Kravitz; John F Randolph; Sioban Harlow; Sybil Crawford; Robin Green; Hadine Joffe
Journal:  Menopause       Date:  2012-09       Impact factor: 2.953

6.  Is there an association between the use of oral contraception and depressive symptoms in young Australian women?

Authors:  Janine M Duke; David W Sibbritt; Anne F Young
Journal:  Contraception       Date:  2006-09-18       Impact factor: 3.375

7.  Bleeding disorders among young women: a population-based prevalence study.

Authors:  Britt Friberg; Ann Kristin Ornö; Annika Lindgren; Stefan Lethagen
Journal:  Acta Obstet Gynecol Scand       Date:  2006       Impact factor: 3.636

Review 8.  Safety of hormonal contraception and intrauterine devices among women with depressive and bipolar disorders: a systematic review.

Authors:  H Pamela Pagano; Lauren B Zapata; Erin N Berry-Bibee; Kavita Nanda; Kathryn M Curtis
Journal:  Contraception       Date:  2016-06-27       Impact factor: 3.375

9.  Depression in adolescence.

Authors:  Anita Thapar; Stephan Collishaw; Daniel S Pine; Ajay K Thapar
Journal:  Lancet       Date:  2012-02-02       Impact factor: 79.321

10.  Hormonal contraception increases the risk of psychotropic drug use in adolescent girls but not in adults: A pharmacoepidemiological study on 800 000 Swedish women.

Authors:  Sofia Zettermark; Raquel Perez Vicente; Juan Merlo
Journal:  PLoS One       Date:  2018-03-22       Impact factor: 3.240

View more
  3 in total

1.  "If I wasn't a girl": Experiences of adolescent girls with heavy menstrual bleeding and inherited bleeding disorders.

Authors:  Mackenzie Parker; Maria Hannah; Ayesha Zia
Journal:  Res Pract Thromb Haemost       Date:  2022-05-30

Review 2.  The Problem of Malnutrition Associated with Major Depressive Disorder from a Sex-Gender Perspective.

Authors:  Cielo García-Montero; Miguel A Ortega; Miguel Angel Alvarez-Mon; Oscar Fraile-Martinez; Adoración Romero-Bazán; Guillermo Lahera; José Manuel Montes-Rodríguez; Rosa M Molina-Ruiz; Fernando Mora; Roberto Rodriguez-Jimenez; Javier Quintero; Melchor Álvarez-Mon
Journal:  Nutrients       Date:  2022-03-06       Impact factor: 5.717

3.  Health issues in women and girls affected by haemophilia with a focus on nomenclature, heavy menstrual bleeding, and musculoskeletal issues.

Authors:  Angela C Weyand; Robert F Sidonio; Michelle Sholzberg
Journal:  Haemophilia       Date:  2022-05       Impact factor: 4.263

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.